WHAT IS AN AMNIOTIC MEMBRANE WOUND GRAFT?
1- Amniotic Membrane Wound Grafts are human allografts prepared from donated amniotic tissue collected using aseptic techniques during Cesarean birth. The surgical site is prepped according to AORN standards for incision disinfection. The tissue is retrieved and processed within 72 hours from time of C-section.
2- Amniotic Membrane Wound Grafts are sterile and durable allografts designed for optimal wound covering and protection during the treatment of wounds. Adheres easily to wounds including those with irregular services.
3- Amniotic Membrane Wound Grafts contain cytokines, growth factors and stem cells to help problematic and non-healing wounds achieve closure at a high rate.
4- Amniotic Membranes Wound Grafts are replaced every 7 days until wound closure is achieved.
5- Average healing interval from first application of an Amniotic Membrane Wound Graft to closure is 6-10 weeks depending on size of wound site.
​B. Amniotic Membrane Wound Grafts are reimbursed by Medicare and other major insurance plans that have gone through an insurance verification form through Alerce Biologix.
i. Patients are preapproved up to 10 weeks after prior authorizations.
WHO BENEFITS FROM AMNIOTIC MEMBRANE WOUND GRAFTS?
​
• Diabetics with reduced sensation or poor circulation
• Poor circulation in feet and legs (PAD) without diabetes
• Patients with venous insufficiency who develop swelling in legs/feet
• Dialysis and transplant patients
• Patients with Raynaud's disease with foot/toe involvement
• Patients with rheumatoid arthritis, lupus, scleroderma
• Patients with Neuropathy and weakened immune system
• Lacerations/burn injuries
• Patients that are unresponsive to other therapies for
healing (periodic debridement, moist dressings, antibiotics, hyperbaric oxygen, glycemic control)
The product may be used as a barrier to protect and heal diabetic ulcers, venous ulcers, pressure ulcers, and other dermal ulcerations that include wounds with exposed vital structures such as tendon, muscle, or bone.
Patients at highest risk for Nonhealing wounds:
78 y/0 with h/o venous insufficiency and venous stasis ulcers. Hit her left leg on car door and stump. Patient administered santyl ointment. Proximal leg ulceration 2cm x 1.6cm x 0.1. 30% necrotic tissue, 40% granulation Tissue, 30% slough. No erythema or purulence. No signs of infection. Completed bilateral noninvasive Quantaflo PAD test with normal range reading. 8 applications of an Amniotic Membrane Protocol for closure.
Pressure Ulcer Patient: Healed with 8 applications of Amniotic Membrane Protocol.